A significant portion of americans are taking glp-1 weight loss drugs, with reports suggesting around 11% or one in 10 are using them. The use of these medications appears to be increasing, with some outlets noting a tripling of usage over two years, and this growth may be linked to a drop in the us obesity rate. The rising popularity of glp-1 weight loss drugs has reached a record high in the country.